Pruritus Therapeutics Market Size, Future Forecasts, Growth Rate, and Industry Analysis 2026


Posted January 21, 2020 by Stephenwilson12

The global pruritus therapeutics market is anticipated to reach over USD 17,275.12 Million by 2026, according to a new research published by Polaris Market Research

 
The global pruritus therapeutics market is anticipated to reach over USD 17,275.12 Million by 2026, according to a new research published by Polaris Market Research, Pruritus, also known as itch disorder can be triggered by several ailments ranging from dermatological disorders such as mycoses, atopic dermatitis, chickenpox, and contact dermatitis, Pruritus is interrelated with the dermatologic and systemic causes. A typical itching generally forms the diagnosis of a key dermatologic syndrome. Several skin diseases that are related to pruritus include renal pruritus, hematologic pruritus, cholestatic pruritus, idiopathic generalized pruritus, pruritus related to malignancy and endocrine pruritus. Renal pruritus can befall in people with chronic renal failure. Increased levels of ions such as calcium, phosphate, and magnesium are found in the skin of pruritic patients. Severe pruritus leads to scratching that causes secondary skin problems such as eczematization, dryness, infection, excoriation, Contact allergy, and lichenification.

Complete Summary with TOC Available @ https://www.polarismarketresearch.com/industry-analysis/global-pruritus-therapeutics-market

The rising incidence of dermatological disorder influencing the occurrence of pruritus and subsequently, the rising demand for proper diagnostics as well as therapeutics to treat the such medical condition is anticipated to bolster the market growth. The rise in inorganic development strategies is recognized as one of the key factor boosting the growth of the pruritus therapeutic market. In addition, the key players of the pruritus therapeutic market are progressively adapting the growth strategies such as partnerships, regional acquirements, and mergers and acquisitions. Such growth strategies are anticipated to result in technological advancement owing to enhancement in the product portfolio and mutual collaboration in R&D further boosting the market growth.

The global pruritus therapeutics market is segmented on the basis of product, disease type, and geography. On the basis of product, the global pruritus therapeutics market is segmented into Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, and Others. In 2017, the corticosteroids are expected to dominate the market by product segment as corticosteroids are widely used as the first line of treatment. On the basis of disease type, the global pruritus therapeutics market is segmented into Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, and Others. In 2017, Allergic contact dermatitis is estimated to dominate the market segment. It is the 3rd most general cause for patients seeking consultation with a dermatology specialist. Allergic contact dermatitis is commonly observed in women.

Get sample copy of this report @ https://www.polarismarketresearch.com/industry-analysis/global-pruritus-therapeutics-market/request-for-sample

On the basis of region, the global pruritus therapeutics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was estimated to dominate the global pruritus therapeutics market. The dominance is majorly due to The presence of favorable government initiatives and the introduction of new products. Moreover, rising incidence of target disorders and the existence of pruritus inducing climatic disorders in this region are anticipated to boost the market growth during the forecast period. However, Asia Pacific is anticipated to dominate pruritus therapeutics market. Growing incidence of atopic dermatitis and urticarial and presence of unmet healthcare organization needs are the factors attributed to the growth of the market in Asia Pacific.

Some major key players in global Pruritus Therapeutics Market include pruritus therapeutics market includes Allergan Inc., Amgen Inc., Astellas Pharma Inc., CARA Therapeutics, Novartis AG, and Teva Pharmaceutical Industries Ltd. among others.

Make Inquiry about this report @ https://www.polarismarketresearch.com/industry-analysis/global-pruritus-therapeutics-market/inquire-before-buying
• Pruritus Therapeutics Market Size and Forecast by Product
o Corticosteroids
o Antihistamines
o Local Anesthetics
o Counterirritants
o Immunosuppressant
o Calcineurin Inhibitors
o Others
• Pruritus Therapeutics Market Size and Forecast by Disease Type
o Atopic Dermatitis
o Allergic Contact Dermatitis
o Urticaria
o Others
• Pruritus Therapeutics Market Size and Forecast by Regions
o North America
 U.S.
 Canada
o Europe
 Germany
 UK
 France
 Italy
o Asia Pacific
 China
 India
 Japan
 Australia
o Latin America
 Brazil
 Mexico
o Middle East & Africa
Avail discount on this report @ https://www.polarismarketresearch.com/industry-analysis/global-pruritus-therapeutics-market/request-for-discount-pricing
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world.
Contact us-
Polaris Market Research
Phone: 1-646-568-9980
Email: [email protected]
Web: www.polarismarketresearch.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Polaris Market Research
Country United States
Categories Business
Tags analysis , growth , share , size , trends
Last Updated January 21, 2020